Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU
Capri23auto / Pixabay

Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU

According to a story from BioPortfolio, the specialty pharmaceutical company Santhera Pharmaceuticals recently announced that it has submitted its marketing application to the European Medicines Agency (EMA) for its drug…

Continue Reading Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU
NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research
source: pixabay.com

NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research

According to a publication on EurekAlert, the National Institutes of Health recently awarded Dr. Jason Karnes, PharmD, PhD (and assistant professor in the University of Arizona College of Pharmacy) with…

Continue Reading NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research
Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
sabinurce / Pixabay

Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from brightsurf.com, familial hypercholesterolemia, a genetic condition that causes elevated levels of LDL cholesterol to appear at a young age, often goes undiagnosed. In fact, some…

Continue Reading Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy
courtesy of US Gov't

Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy

In a letter to Dr. Norman Sharpless, the acting commissioner of the Food and Drug Administration since April 5, Senator Ted Cruz encouraged the federal agency to expand the number…

Continue Reading Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy